Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fass

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1991
In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciR J Fass
The Journal of Antimicrobial Chemotherapy|November 1, 1986
Treatment of skin and soft tissue infections with oral ciprofloxacinR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1993
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistanceR J Fass
Antimicrobial Agents and Chemotherapy|February 1, 1981
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas speciesR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1983
In vitro activity of ciprofloxacin (Bay o 9867)R J Fass
Antimicrobial Agents and Chemotherapy|February 1, 1987
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infectionsR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1979
In vitro activity of LY127935R J Fass
Journal of Bacteriology|February 1, 1973
Morphology and ultrastructure of staphylococcal L colonies: light, scanning, and transmission electron microscopyR J Fass
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro activity of BAY v 3522, a new oral cephalosporinR J Fass
Antimicrobial Agents and Chemotherapy|January 1, 1982
In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas speciesR J Fass
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|March 1, 1991
In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciR J Fass
The Journal of Antimicrobial Chemotherapy|November 1, 1986
Treatment of skin and soft tissue infections with oral ciprofloxacinR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1993
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistanceR J Fass
Antimicrobial Agents and Chemotherapy|February 1, 1981
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas speciesR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1983
In vitro activity of ciprofloxacin (Bay o 9867)R J Fass
Antimicrobial Agents and Chemotherapy|February 1, 1987
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infectionsR J Fass
Antimicrobial Agents and Chemotherapy|October 1, 1979
In vitro activity of LY127935R J Fass
Journal of Bacteriology|February 1, 1973
Morphology and ultrastructure of staphylococcal L colonies: light, scanning, and transmission electron microscopyR J Fass
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro activity of BAY v 3522, a new oral cephalosporinR J Fass
Antimicrobial Agents and Chemotherapy|January 1, 1982
In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas speciesR J Fass
Pageof 20